Advertisement

Topics

Synergy Pharmaceuticals, Inc. Company Profile

18:20 EST 18th November 2017 | BioPortfolio

Synergy is a biopharmaceutical company focused on the development of new drugs to treat gastrointestinal disorders and diseases. Synergy's proprietary drug SP-304 is a synthetic analog of the human gastrointestinal hormone uroguanylin, and acts by activating the guanylate cyclase C (GC-C) receptor on epithelial cells of the GI tract. SP-304 has completed a Phase I clinical trial in volunteers and is presently in a Phase 2a clinical trial of SP-304 in patients to treat chronic constipation. The Company expects to obtain topline data from this trial in 2010, and use those data to begin a Phase 2b 28-day repeated-oral-dose, placebo-controlled trial in SP-304 in CC patients in early 2011 and a Phase 2b 90-day repeated-oral-dose, placebo-controlled trial of SP-304 in IBS-C patients in the second quarter of 2011. More information is available at http://www.synergypharma.com.


News Articles [544 Associated News Articles listed on BioPortfolio]

Synergy Pharmaceuticals nets $52.6mm via FOPO

Gastrointestinal disease-focused Synergy Pharmaceuticals Inc. netted $52.6mm through the follow-on public offering of 21.7mm common shares at $2.58. The company also issued two-year warrants to buy 21...

Synergy Pharma To Highlight New Data For TRULANCE (Plecanatide) At (WCOG) At American College of Gastroenterology

Synergy to also present new insights from the BURDEN IBS-C study, which evaluated patient and physician perceptions on irritable bowel syndrome with constipation (IBS-C) NEW YORK-...

Synergy Pharmaceuticals to Highlight New Data for TRULANCE® (Plecanatide) at the World ...

Synergy to also present new insights from the BURDEN IBS-C study, which evaluated patient and physician perceptions on irritable bowel syndrome with constipation (IBS-C) Read more.....

Synergy Pharmaceuticals to Report Third Quarter 2017 Financial Results and Host Conference Call and Webcast

Synergy Pharmaceuticals Inc. (NASDAQ: SGYP) today announced it intends to release third quarter 2017 financial results after the NASDAQ market close on Thursday, November 9, 2017....

Synergy Pharmaceuticals to Present at Upcoming September Investor Conferences

Synergy Pharmaceuticals Inc. (NASDAQ: SGYP) today announced that the company will present corporate updates at three upcoming investor conferences in New York City during Septembe...

CORRECTING and REPLACING Synergy Pharmaceuticals to Present at Upcoming September Investor Conferences

In the release dated September 6, 2017, the presentation date and time for the Cantor Fitzgerald Global Healthcare Conference should be changed to Wednesday, September 27, 2017 at...

Is Synergy Pharmaceuticals A Buy?

Synergy Pharmaceuticals: Risky But Still A Buy

Drugs and Medications [274 Associated Drugs and Medications listed on BioPortfolio]

Endure 200 [Ecolab Inc.]

Drug Facts

Pur-wash [Niagara Pharmaceuticals Inc.]

Pur-Wash

Bacitracin [Qualitest Pharmaceuticals]

Bacitracin Ointment, USP

Pur-wash [Niagara Pharmaceuticals Inc.]

Pur-Wash Purified Water, 98.3% Ophthalmic Solution Eyewash

Antacid [Major Pharmaceuticals]

Major Pharmaceuticals Antacid Tablets Drug Facts

PubMed Articles [209 Associated PubMed Articles listed on BioPortfolio]

Flexion synergy overshadows flexor spasticity during reaching in chronic moderate to severe hemiparetic stroke.

Pharmaceutical intervention targets arm flexor spasticity with an often-unsuccessful goal of improving function. Flexion synergy is a related motor impairment that may be inadvertently neglected. Here...

Announcing the 2017 Pharmaceuticals Travel Award for Young Post-Doctoral Researchers.

Last year, for the first time in its history, our Journal was able to offer a travel grant of 800 CHF to a young researcher in the field of medicinal chemistry.

Suspended solids moderate the degradation and sorption of waste water-derived pharmaceuticals in estuarine waters.

This study focuses on the fate of pharmaceuticals discharged into an estuarine environment, particularly into the Turbidity Maximum Zone (TMZ). Batch experiments were set up to investigate the factors...

Chiral pharmaceuticals: A review on their environmental occurrence and fate processes.

More than 50% of pharmaceuticals in current use are chiral compounds. Enantiomers of the same pharmaceutical have identical physicochemical properties, but may exhibit differences in pharmacokinetics,...

Co-gasification of coal and biomass: Synergy, characterization and reactivity of the residual char.

The synergy effect between coal and biomass in their co-gasification was studied in a vertical fixed bed reactor, and the physic-chemical structural characteristics and gasification reactivity of the ...

Clinical Trials [270 Associated Clinical Trials listed on BioPortfolio]

A 2x2 Factorial Randomized Controlled Trial of Colchicine and Spironolactone in Patients With STEMI Who Have Undergone PCI With SYNERGY Stent Registry

The CLEAR SYNERGY trial will study the long term effects of three multidisciplinary treatments following PCI to treat ST elevation myocardial infarction. These treatments address both the ...

IRIS-Synergy Cohort in the IRIS-DES Registry

The purpose of this study is to evaluate the relative effectiveness and safety of Synergy stent compared to other drug eluting stents.

Safety and Performance Evaluation of CircuLite Synergy

The purpose of the study is to demonstrate the safety and functionality of the CircuLite Synergy Pocket Circulatory Assist Device.

Registry Experience at the Washington Hospital Center With Drug Eluting Stents - Synergy

To compare the incidence of major adverse cardiac events among a series of patients receiving the Synergy drug-eluting stent with bioabsorbable polymer to historical controls who have rece...

SYNERGY China: Assess SYNERGY Stent in China

Prospective, multicenter, single-arm study, enroll 100 patients in no more than 10 sites across China, the primary endpoint is Technical success.

Companies [1333 Associated Companies listed on BioPortfolio]

Synergy Pharmaceuticals, Inc.

Synergy is a biopharmaceutical company focused on the development of new drugs to treat gastrointestinal disorders and diseases. Synergy's proprietary drug SP-304 is a synthetic a...

Synergy Pharmaceuticals Inc.

Synergy Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development of new drugs to treat patients with gastrointestinal (GI) diseases and disorders. Synergyâ...

Synergy Health Concepts

The team at Pacific Interventionalists launched Synergy Health Concepts to focus specifically on CCSVI treatment and care. Chronic Cerebro-Spinal Venous Insufficiency (CCSVI) is c...

Synergy Strips Corp.

Synergy Strips Corp. (OTCQB:SNYR) is a consumer health care company, that is in the process of building a portfolio of best-in- class consumer product brands. Synergy's strategy i...

BIND Therapeutics and Synergy Pharmaceuticals

More Information about "Synergy Pharmaceuticals, Inc." on BioPortfolio

We have published hundreds of Synergy Pharmaceuticals, Inc. news stories on BioPortfolio along with dozens of Synergy Pharmaceuticals, Inc. Clinical Trials and PubMed Articles about Synergy Pharmaceuticals, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Synergy Pharmaceuticals, Inc. Companies in our database. You can also find out about relevant Synergy Pharmaceuticals, Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Endocrinology
Diabetes Diabetes Endocrine Obesity Oxycontin Renal Disease Thyroid Disorders Endocrinology is the study of the endocrine glands and the hormones that they secrete (Oxford Medical Dictionary). There are several groups of h...


Corporate Database Quicklinks



Searches Linking to this Company Record